These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension. Mallion JM; Goldberg AI Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546 [TBL] [Abstract][Full Text] [Related]
30. A risk-benefit assessment of losartan potassium in the treatment of hypertension. Burrell LM Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643 [TBL] [Abstract][Full Text] [Related]
31. Losartan for hypertension. Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693 [No Abstract] [Full Text] [Related]
32. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Goldberg AI; Dunlay MC; Sweet CS Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281 [TBL] [Abstract][Full Text] [Related]
33. [Angiotensin II receptor antagonists]. Bornkessel B Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710 [No Abstract] [Full Text] [Related]
34. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266 [TBL] [Abstract][Full Text] [Related]
35. Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report. Weber MA Am J Hypertens; 1992 Dec; 5(12 Pt 2):247S-251S. PubMed ID: 1290620 [TBL] [Abstract][Full Text] [Related]
36. Drug reduction in the elderly. Freeman JW S D J Med; 1996 Dec; 49(12):439. PubMed ID: 8997149 [No Abstract] [Full Text] [Related]
37. Acute oliguric renal failure associated with angiotensin II receptor antagonists. Lee HY; Kim CH Am J Med; 2001 Aug; 111(2):162-3. PubMed ID: 11501548 [No Abstract] [Full Text] [Related]
38. Angiotensin II receptor inhibition. A new therapeutic principle. Messerli FH; Weber MA; Brunner HR Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149 [TBL] [Abstract][Full Text] [Related]
39. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension. Ogihara T; Yoshinaga K Blood Press Suppl; 1996; 2():78-81. PubMed ID: 8913545 [TBL] [Abstract][Full Text] [Related]
40. Angiotensin receptor antagonists as a treatment for hypertension. MacFadyen RJ; Reid JL J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]